Search
for
Sort by
Research 661–690 of 1000+
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- The mechanisms of MicroRNA 21 in premature ovarian insufficiency mice with mesenchymal stem cells transplantation
- Assessment of the quality of the healing process in experimentally induced skin lesions treated with autologous platelet concentrate associated or unassociated with allogeneic mesenchymal stem cells: preliminary results in a large animal model
- The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Real-World Outcomes and Healthcare Utilization of Lanadelumab in Spain: Insights from First Cohort of Difficult-to-Treat Hereditary Angioedema Cases
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- 050 Evaluation of 3 month data for the use of erenumab for chronic migraine in Glasgow
- Resistance Training Ameliorates Finasteride-Induced Disturbance in Protein Homeostasis in Skeletal Muscle of Rats
- The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis
- Alopecia Areata Associated with Dupilumab: National Database Study
- Disruption of tubular Flcn expression as a mouse model for renal tumor induction
- Spherical Nucleic Acids as Emerging Topical Therapeutics: A Focus on Psoriasis
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis
- Platelet-derived extracellular vesicles promote hair follicle growth through β-catenin signaling pathway
- “PRIDE” Complex
- Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
- New oral anticoagulants and their reversal agents
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- LB1256 TRIV-509, a dual inhibitor of KLK5 and KLK7, rapidly improves barrier integrity and markers of epidermal differentiation in atopic dermatitis skin explants
- North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
- Mechanism of Targeting the Hedgehog Signaling Pathway against Chemotherapeutic Resistance in Multiple Myeloma
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- A narrative review of SARS-CoV-2 variants and long COVID
- Resolution of Waldenström's macroglubulinemia related isolated neutropenia by immunochemotherapy
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Autofluorescence in the Stem Cell Region of the Hair Follicle Bulge